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Abstract Nephropathic cystinosis is a rare genetic
metabolic disorder that results in accumulation of the
amino acid cystine in lysosomes due to lack of a cystine-
specific transporter protein. Cystine accumulates in cells
throughout the body and causes progressive damage to
multiple organs, including the brain. Neuromotor deficits
have been qualitatively described in individuals with
cystinosis. This study quantitatively examined fine-motor
coordination in individuals with cystinosis. Brain mag-
netic resonance imaging (MRI) scans were also per-
formed to determine whether structural changes were
associated with motor deficits. Participants were 52
children and adolescents with infantile nephropathic
cystinosis and 49 controls, ages 2–17 years, divided into
preacademic and school-age groups. Results indicated
that both the preacademic and school-age cystinosis
groups performed significantly more poorly than their
matched control groups on the Motor Coordination Test.
Further, the level of performance was not significantly
different between the preacademic and school-age
groups. There were no significant differences in motor
coordination scores based on MRI findings. This is the
first study to document a persistent, nonprogressive, fine-
motor coordination deficit in children and adolescents
with cystinosis. The fact that these difficulties are present
in the preschool years lends further support to the theory
that cystinosis adversely affects neurological functioning
early in development. The absence of a relationship
between brain structural changes and motor function
suggests that an alternative cause for motor dysfunction
must be at work in this disorder.
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Introduction
Nephropathic cystinosis is a rare genetic metabolic
disorder that results in accumulation of the amino acid
cystine in lysosomes due to lack of a cystine-specific
transporter protein [1–3]. The infantile form of the
disorder is typically diagnosed with failure to thrive and
renal dysfunction (Fanconi syndrome) in the first year of
life [4]. Cystine accumulates in cells throughout the body
and causes progressive damage to multiple organs,
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cystine crystals within neural tissue [5, 6]. Central nervous
system (CNS) involvement has been demonstrated in
neuroimaging studies, which have documented cerebral
atrophy and central volume loss [7–9]. Studies have linked
brain structure and various aspects of cognition in
individuals with cystinosis [10–12]. Most of those studies,
however, took place before the advent of an effective
treatment for the disease. Since the use of cysteamine has
become the standard treatment for individuals with
cystinosis, preservation of renal function is now possible
for many years. Possible prevention of brain abnormalities
must also be considered in light of current treatment.
Neuropsychological studies have shown that individuals
with cystinosis have IQ and language within the normal
range [13, 14] but specific nonverbal deficits [15, 16]. In
particular, deficits are seen in the domains of visual spatial
skills, visual–motor integration, visual memory, and pro-
cessing speed, with a sparing of visual perception [15–19].
This specific pattern has been observed across the age range
from preschool through adulthood [15, 16, 18], suggesting
the possibility that the genetic disorder may exert a very
early effect on brain development rather than the neuro-
logical effects being the result of a progressive decline in
cognitive functioning as cystine continues to accumulate in
the brain.
Neuromotor deficits in cystinosis were qualitatively
described more than 20 years ago [7, 8, 20]. In this study,
we greatly expand on the previous observations by
examining fine-motor coordination in a large group of
children and adolescents with cystinosis, all of whom have
been treated with cysteamine since early life. We used the
standardized Motor Coordination Test of the Beery-
Buktenica Developmental Test of Visual-Motor Integration
(VMI-5) [21] to obtain a quantitative assessment of motor
coordination. Magnetic resonance imaging (MRI) scans
were performed on all children and adolescents in the study
with cystinosis so that structure–function analyses could be
performed. We hypothesized that children and adolescents
with cystinosis would exhibit fine-motor difficulties on the
VMI-5 Motor Coordination Test. This study also examined
fine-motor skills as a function of age group, which may
shed light on the underlying pathophysiology of the
disease.
Methods
Participants
Participants were 52 children and adolescents with
infantile nephropathic cystinosis and 49 controls, ages
2–17 years. The cystinosis and control groups were
divided into preacademic (ages 2–5 years) and school-
age (ages 6–17 years) groups due to the many develop-
mental and academic milestones that occur at the start of
school (e.g. ability to hold a pencil to write) that might
be expected to influence fine-motor performance. This
testing was part of a larger, longitudinal study of brain
structure and function in cystinosis. Each participant was
diagnosed with infantile nephropathic cystinosis, as
confirmed by clinical presentation and by assays doc-
umenting elevated leukocyte cystine concentrations.
Individuals with cystinosis were excluded from the study
if they were in renal failure, were on dialysis, were
acutely ill, or had any other condition that might
adversely affect cognitive function. Unfortunately, we
were unable to acquire specific information about renal
function on most of the patients because of variability in
response from their treating physicians, variability in
timing of blood and urine tests around the time of our
testing, and differences in the types of tests performed by
the treating physicians. However, some of these children
participated in another study at the same time as ours,
and all had estimated glomerular filtration rates (eGFRs)
between 79 and 122 mL/min per 1.73 m
2 or stage 1 or 2
kidney disease [22]. At the time of testing, all cystinosis
participants were on the standard prescribed medical
regimen, which includes cysteamine, vitamin D, calcium
and phosphate replacement, and thyroid hormone [23].
Cystinosis participants were recruited through the Cysti-
nosis Foundation, the Cystinosis Research Network, and
the Cystinosis Research Foundation. Participants in the
control group were identified through advertisements
placed in parent magazines and by fliers placed at various
venues for children throughout the community (e.g.
public libraries, YMCAs). The cystinosis and control
participants were group-matched on the demographic
variables of sex, chronological age, and socioeconomic
status (SES) based on the Hollingshead Four Factor Index
of Social Status [24]. All controls had normal develop-
mental and medical histories. Informed consent for each
participant was obtained according to the University of
California, San Diego, Human Research Protection Pro-
gram (HRPP) procedures, and the study was approved by
the HRPP.
Measures
Fine-motor coordination
The Motor Coordination Test of the VMI-5 [21]w a s
administered to all participants. The VMI-5 is normed for
individuals between the ages of 2 years 0 months and
18 years 11 months and yields a standard score with a
mean of 100 and standard deviation (SD) of 15. All
2062 Pediatr Nephrol (2010) 25:2061–2066participants were presented with a series of geometric
designs and required to draw each design within a double-
lined path without going outside the lines. Items increased
in difficulty throughout the test. Children younger than
5 years of age first demonstrated whether they were able
to sit in a chair without help, hold a pencil with thumb and
fingertips, and hold paper with one hand and draw with
the other.
Intellectual ability
All cystinosis and control participants received an age-
appropriate Wechsler Intelligence Scale [Wechsler Preschool
and Primary Scale of Intelligence - III (WPPSI-III), Wechsler
Intelligence Scale for Children - III (WISC-III), WISC-
IV, or Wechsler Adult Intelligence Scale - III (WAIS-III)]
[25–28]. Sixty-two participants received the WPPSI-III,
27 the WISC-III, ten the WISC-IV, and two the WAIS-III.
Since the WISC-IV does not yield Verbal IQ (VIQ) or
Performance IQ (PIQ) scores, the WISC-IV Verbal
Comprehension Index (VCI) was substituted for VIQ and
the WISC-IV Perceptual Reasoning Index (PRI) was
substituted for PIQ.
Brain neuroimaging
Brain MRI scans were attempted on all participants with
cystinosis. Scans were successfully completed on 46
children and adolescents. All scans were performed on a
GE 1.5-Tessla unit at UCSD and were independently
reviewed by a neuroradiologist (JH) who had no informa-
tion on the participants’ diagnoses. Scans were rated as
normal, mild volume loss, and moderate to severe volume
loss. Isolated Chiari type I malformations were also
identified as a separate category.
White blood cell cystine levels
We were able to obtain results of white blood cell (WBC)
cystine levels measured within 1 month of our testing from
physicians caring for 29 participants. We were unable to
acquire information about the methods used to measure
cystine levels.
Statistical analyses
Potential group differences between the cystinosis and control
groups within both the preacademic and school-age groups on
the demographic variables of age at the time of testing, SES,
sex,VIQ,andPIQwereanalyzedusingindependent t tests and
chi-square analyses, as appropriate. Analysis of variance
(ANOVA) and analysis of covariance (ANCOVA) frame-
works were used to analyze potential differences on the
Motor Coordination Test between the cystinosis and control
groups and between the preacademic and school-age groups.
ANOVA was also used to determine whether brain structural
differences were associated with motor coordination results.
Lastly, the relationship between age and MRI findings was
analyzed using a correlation analysis.
Results
Demographic variables
Table 1 lists group means, SDs, and significance values
for the demographic variables. In the preacademic group,
there were no significant differences between the cysti-
nosis and control groups on Age at Testing, SES, or VIQ;
however, PIQ was significantly lower in the cystinosis
group compared with the control group (t=-2.491,
Table 1 Summary of demographic variables and significance values for the cystinosis and control groups
Preacademic group School-age group
n=50 n=51
Cystinosis Control p Cystinosis Control p
n=26 n=24 n=26 n=25
Mean Age at Testing 4y 2m±9m 4y 4m±11m NS 10y 8m±3y 7m 9y 9m±3y 3m NS
Mean SES
a 2.27±0.96 2.21±1.02 NS 1.92±0.84 1.84±0.90 NS
Sex 13 M; 13 F 14 M; 10 F NS 18 M; 8 F 15 M ; 10 F NS
VIQ 97.85±11.52 101.04±8.76 NS 92.23±13.39 102.96±7.99 0.001
PIQ 90.27±13.04 100.33±15.32 0.02 88.27±16.40 107.32±15.33 <0.001
aBased on the Hollingshead Four Factor Index of Social Status [23], with 1 being the highest and 5 being the lowest socioeconomic status
y years, m months, M male, F female, SES socioeconomic status, VIQ Verbal IQ, PIQ Performance IQ
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significant differences between the cystinosis and control
groups on Age at Testing or SES. Although still within
normal limits, VIQ and PIQ were significantly lower in
the cystinosis group than in the control group (t=-3.489,
p=0.001; t=-4.281, p≤0.001, respectively).
VIQ and PIQ were individually assessed as covariates
for the analysis of motor coordination and were found to
contribute a significant portion of variance to Motor
Coordination Test scores. Nonetheless, when either VIQ
or PIQ was partialled out, all significant differences
between the cystinosis and control groups remained. Due
to the fact that the analysis of Motor Coordination scores
with IQ as a covariate is somewhat artificial (i.e. the
child functions as a unitary whole), and significant
differences remained even after covarying for either
VIQ or PIQ, the results presented below represent
performance without IQ as a covariate.
Fine-motor coordination
Fig. 1 presents Motor Coordination Test performance in
preacademic and school-age cystinosis and control groups.
ANOVA results indicated that the cystinosis group
performed significantly more poorly than the control
group on the Motor Coordination Test (F=32.01,
p<0.001). Follow-up ANOVAs showed this pattern was
significant within both the preacademic (F=12.39,
p=0.001) and school-age (F=20.12, p<0.001) groups.
ANOVA results showed the level of performance on the
Motor Coordination Test was not significantly different
between the preacademic and school-age groups. In
addition, well over half of the cystinosis participants
(approximately 60%) performed below normal limits
(standard score<85) on the Motor Coordination Test,
whereas one fifth (approximately 20%) of control
participants scored below normal limits.
Brain neuroimaging
Of the 46 useable MRI scans performed on cystinosis
participants, 25 were read as normal, 11 had mild
volume loss, five had moderate to severe volume loss,
and five had an isolated Chiari I malformation (see Fig. 2
for control and cystinosis participant MRI examples). No
significant differences were detected in motor coordina-
tion scores based on MRI findings (see Table 2). Although
the group with mild volume loss achieved a higher score
Fig. 1 Mean standard scores on the Motor Coordination Test for the
cystinosis and control preacademic and school-age groups
Fig. 2 a Brain magnetic reso-
nance image (MRI) of 4-year-
old typically developing control.
b Brain MRI of a 5-year-old
child with cystinosis, demon-
strating mild central volume loss
with ventriculomegaly
Table 2 Mean score (± standard deviation) on the Motor Coordina-
tion Test according to brain magnetic resonance imaging (MRI)
findings in the cystinosis group
Normal
MRI
(n=25)
Mild volume
loss
(n=11)
Moderate to
severe volume
loss (n=5)
Isolated Chiari I
malformation
(n=5)
77.8±13.7 87.8 ±15.6 75.6±12.5 76.2±11.5
There were no significant differences between the Normal MRI group
and any of the three abnormal MRI subgroups
2064 Pediatr Nephrol (2010) 25:2061–2066on motor coordination than did the group with normal
scans, this difference was not statistically significant. In
addition, the groups with moderate to severe volume loss
or an isolated Chiari I malformation demonstrated no
differences in performance when compared with the group
with normal scans. It should be noted, however, that there
were small numbers of children in the abnormal scan
subgroups. Furthermore, there were no age-related differ-
ences in MRI findings. Specifically, there was no
correlation between age at scanning and presence or
absence of brain-volume loss.
We did not record the dose of cysteamine that each
child was taking at the time of testing. However,
leukocyte cystine levels drawn within 1 month of
psychometric testing were available for 29 cystinosis
patients. Twenty-one of these 29 had values of 1.0 nmol
half cystine per milligram of protein, the current
therapeutic goal for treatment of cystinosis [29]. All but
two of the 29 samples had cystine levels <2 nmol half
cystine per milligram of protein, a level thought to be
adequate to diminish the rate of decline in renal function
[30]. There was no difference in motor coordination scores
for the two children whose cystine levels were >2
compared with those whose levels were <2, although no
statistical analyses could be performed due to the small
number of children with high cystine levels.
Discussion
This is the first study to document a persistent,
nonprogressive, fine-motor-coordination deficit in cysti-
nosis individuals using a quantitative standardized
assessment tool. Mean scores on the Motor Coordination
Test in both the preacademic and school-age cystinosis
groups were below normal compared with age-
referenced norms (mean scores 79.58 and 78.08, respec-
tively) and were significantly lower than matched
control groups. Of note, this fine-motor coordination
deficit is not due to the influence of cognitive ability
(either VIQ or PIQ) and thus represents a unique
neuromotor component of the disease. Furthermore, this
is the first study to document that brain MRI findings do
not explain the motor coordination deficits in a group of
cystinosis individuals, all of whom received early
treatment with cysteamine.
Importantly, our results show that the fine-motor
coordination deficit in cystinosis is present from the
preschool years and persists throughout adolescence.
They also demonstrate that brain structural changes do
not account for the observed motor coordination deficits.
The fact that both structural and functional changes are
present in the preschool years lends further support to
the theory that cystinosis adversely affects the brain early
in development [16, 18]. Possible causes of this early
negative impact on brain structure and function include an
adverse effect of very early cystine accumulation in the
brain (possibly in utero) prior to the introduction of
treatment with cysteamine, or a direct effect of the gene
on brain development. It is also possible that treatment
with cysteamine could be responsible for motor coordina-
tion problems; however, earlier reports of fine-motor
deficits in cystinosis individuals [20] included individuals
who had never received cysteamine, making it less likely
that treatment of the underlying disease is responsible for
the neuromotor abnormalities. Finally, it is possible that
cysteamine is improving neurological function and that
the children might have more severe deficits had they not
been on this treatment. Further studies will be required to
clarify this question.
The finding of significant motor coordination deficits in
children with cystinosis has important implications for
intervention. Early recognition and treatment of such
problems may lead to improved life skills, such as self-
care (buttoning, using scissors, manipulating utensils),
writing, drawing, eye–hand coordination, and academic
and vocational ability, potentially leading to improved
quality of life.
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